(Q40607441)

22 September 2017

1 reference

title

Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis (English)

1 reference

22 September 2017

0 references

Hodson ME

1

1 reference

PubMed ID

7881698

22 September 2017

language of work or name

English

0 references

publication date

1 March 1995

1 reference

American Journal of Respiratory and Critical Care Medicine

22 September 2017

1 reference

22 September 2017

151

1 reference

22 September 2017

3 Pt 2

1 reference

22 September 2017

S70-4

1 reference

Cystic fibrosis in adolescents and adults

22 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

Pus, deoxyribonucleic acid, and sputum viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

Deoxyribonuclease in the treatment of purulent bronchitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

Dornase Aerosol Effect on Sputum Viscosity in Cases Of Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F151.3_PT_2.S70

10.1164/AJRCCM/151.3_PT_2.S70

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

7881698